The Gentlemen lost a lot of viewership for season 2, but not because of the quality of the show. This is Netflix’s biggest problem it must deal with.
FDA-approved daraxonrasib targets RAS in metastatic pancreatic cancer, doubling median survival versus chemotherapy and delivering a long-awaited treatment advance.
Timnit Gebru argues that AI companies are stoking fears of extinction to avoid discussing actual harms, like autonomous weapons.
Amazon will let advertisers buy ads in ChatGPT through its own advertising platform. Amazon Ads announced the partnership with OpenAI in a blog post on 10 September. Select US advertisers are already testing it in a pilot. Advertisers who plan and run …
Anthropic has built a model of how AI might reshape the US economy by 2030. Its most extreme case describes an economy roughly a third larger than it would otherwise be. That same case carries knowledge-work unemployment near 18 percent. The company pu…
Oracle told investors this week that it is sitting on $664bn of work it has agreed to do and has not yet done. Accountants call this remaining performance obligations, which is a dense way of saying that customers have signed contracts, the money is pr…
A combination of rapid advances, recursive self-improvement, and agentic swarms are genuinely “spooking people” inside big labs.
“If there is a way in, the modern AI threat will find it,” Kevin Mandia wrote in March, in the blog post that launched his cybersecurity startup, Armadin. Six months later, Amazon has elected him to its board of directors. Amazon announced the appointm…
Amid the latest U.S. Open creator controversy, Wimbledon does not plan dedicated creator accreditation for 2027, unlike U.S. Open and FIFA-TikTok models.
Sergey Brin holds no executive title at Google. He has nonetheless become increasingly influential over Gemini, the company’s flagship AI model, Business Insider reported, citing eight current and former employees. The Google cofounder works from a con…